Results 71 to 80 of about 10,965 (175)

MiR-503 enhances the radiosensitivity of laryngeal carcinoma cells via the inhibition of WEE1

open access: yesTumor Biology, 2017
Enhancing the sensitivity of laryngeal cells to radiation is crucial for improving the efficacy of laryngeal carcinoma. MicroRNAs are known to play a major role in regulating cellular radiosensitivity.
Huimin Ma   +6 more
doaj   +1 more source

XRCC1 deficient triple negative breast cancers are sensitive to ATR, ATM and Wee1 inhibitor either alone or in combination with olaparib

open access: yesTherapeutic Advances in Medical Oncology, 2020
Background: PARP inhibitor (PARPi) monotherapy is a new strategy in BRCA germ-line deficient triple negative breast cancer (TNBC). However, not all patients respond, and the development of resistance limits the use of PARPi monotherapy.
Reem Ali   +7 more
doaj   +1 more source

Targeting WEE1 in tumor-associated dendritic cells potentiates antitumor immunity via the cGAS/STING pathway

open access: yesCell Reports
Summary: DNA damage profoundly affects cancer progression and immune cell function. While research primarily focuses on tumor cells, the effects of DNA damage on immune cells remain understudied.
Ian-Ian Ng   +8 more
doaj   +1 more source

Wee1 Inhibitor AZD1775 Effectively Inhibits the Malignant Phenotypes of Esophageal Squamous Cell Carcinoma In Vitro and In Vivo

open access: yesFrontiers in Pharmacology, 2019
Esophageal squamous cell carcinoma (ESCC) is a common malignant diagnosed cancer with increasing incidence rate and few treatment options. As a specific small-molecule inhibitor of the Wee1 tyrosine kinase, AZD1775 has previously shown potent antitumor ...
Shuning Bi   +5 more
doaj   +1 more source

WEE1 kinase is a therapeutic vulnerability in CIC-DUX4 undifferentiated sarcoma

open access: yesJCI Insight, 2022
CIC-DUX4 rearrangements define an aggressive and chemotherapy-insensitive subset of undifferentiated sarcomas. The CIC-DUX4 fusion drives oncogenesis through direct transcriptional upregulation of cell cycle and DNA replication genes.
Rovingaile Kriska M. Ponce   +4 more
doaj   +1 more source

Spatiotemporal regulations of Wee1 at the G2/M transition

open access: yesMolecular Biology of the Cell, 2011
Wee1 is a protein kinase that negatively regulates mitotic entry in G2 phase by suppressing cyclin B–Cdc2 activity, but its spatiotemporal regulations remain to be elucidated. We observe the dynamic behavior of Wee1 in Schizosaccharomyces pombe cells and manipulate its localization and kinase activity to study its function.
Masuda, Hirohisa   +4 more
openaire   +2 more sources

Expression and clinical significance of Wee1 in colorectal cancer

open access: yesTumor Biology, 2016
Wee1 is a nuclear kinase regulating cell cycle progression, and has emerged as a promising therapeutic target in cancer. Expression of Wee1 has been associated with poor outcome in certain tumor types, but the prognostic impact and clinical significance in colorectal cancer is unknown.
Eivind Valen, Egeland   +5 more
openaire   +2 more sources

High WEE1 expression is independently linked to poor survival in multiple myeloma

open access: yesBlood Cancer Journal
Current prognostic scores in multiple myeloma (MM) currently rely on disease burden and a limited set of genomic alterations. Some studies have suggested gene expression panels may predict clinical outcomes, but none are presently utilized in clinical ...
Anish K. Simhal   +8 more
doaj   +1 more source

WEE1 tyrosine kinase (WEE1) [PDF]

open access: yesScience-Business eXchange, 2012
openaire   +1 more source

WEE1 tyrosine kinase (WEE1) [PDF]

open access: yesScience-Business eXchange, 2010
openaire   +1 more source

Home - About - Disclaimer - Privacy